Overview
ETC vs Injective is one of the most watched crypto matchups. Beyond headline prices, this comparison blends market structure, technical readings and probabilistic context without promising outcomes.
Quick winners
Full comparison
| Metric | ETC | INJ |
|---|---|---|
| Price | $6.62 | $5.07 |
| Market Cap | $1.04B | $490.41M |
| FDV | — | — |
| Volume 24h | $1.00M | $2.62M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 65.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.50% | +5.78% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | ETC | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +1.69% | +3.42% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | ETC | INJ |
|---|---|---|
| RSI | 54.31 | 53.92 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 66.45 | 0.29 |
| ADX | 20.44 | 12.69 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for ETC/INJ currently lean on separate regimes: bearish versus neutral. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | ETC | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
ETC
Injective
Pros and cons
Pros of ETC
- ETC has an established coin page footprint on PEPS for continuous monitoring.
- Higher ranking for ETC can translate into tighter spreads on major venues.
- Market-cap scale on ETC may dampen some idiosyncratic shocks versus smaller peers.
- Composite PEPS readings for ETC can surface clearer module agreement during trend phases.
Cons of ETC
- Regulatory or macro headlines can hit ETC harder simply because it is more visible.
- Large-cap status for ETC can mean slower percentage upside versus high-beta alternatives.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
Pros of Injective
- Diversifying versus ETC with Injective can change portfolio factor exposure.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- If technical momentum aligns, Injective may outperform on medium-term windows.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
Data currently points to a probabilistic edge for ETC on size and Injective on activity. Neither reading guarantees future returns.
AI summary
This AI-assisted summary starts from live PEPS fields. ETC holds market-cap $1.04B and rank #65; Injective shows $490.41M and #99. Where liquidity and flow matter, watch Injective. Where durability matters, watch ETC. AI composite scores (56.80/48.80) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, ETC or Injective?
“Better” depends on horizon and risk. ETC leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, ETC or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both ETC and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.